On this page · 4 sections→
Where the EU money came from
Funding by EU programme. Amounts are Avanther Therapeutics SL's own share of each project, not the project's full budget.
- Horizon Europe€513k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- iN-KEYPartner
iNK Cell–Driven Strategies for Enhanced Multiple Myeloma ImmunotherapY
Horizon Europe · 2026–2031 · Project on CORDIS ↗
€513ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 1 shared project
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
- Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos IiiSpain · 1 shared project
- Bundesinstitut Fur Impfstoffe und Biomedizinische ArzneimittelGermany · 1 shared project
- Eatris EricNetherlands · 1 shared project
- Institut Catala D'OncologiaSpain · 1 shared project
- Fundacio Institut D'Investigacio Biomedica de BellvitgeSpain · 1 shared project
- Miltenyi Biotec BV & Co KGGermany · 1 shared project
- Banc de Sang i TeixitsSpain · 1 shared project
- Catalent Dusseldorf GmbHGermany · 1 shared project
- Stab Therapeutics SLSpain · 1 shared project
- Myeloma Patients Europe AISBLBelgium · 1 shared project
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.